支气管热塑术在耐火性喘中与严重阻塞性呼吸功能障碍的安全性和有效性
Takahiro Inoue1, Sumito Isogai2, Naoki Yamamoto3
1Department of Respiratory Medicine, Fujita Health University School of Medicine, Kutsukake-cho, Toyoake, Aichi, Japan.
Therapeutic advances in respiratory disease
|May 28, 2024
概括
支气管热塑术 (BT) 可以安全有效地改善严重空气流限制患者的喘症状. 这种非药物治疗的结果与中度空气流量限制患者的结果相似.
科学领域:
- 肺部病理学 肺部病理学
- 医疗器械 医疗器械
- 呼吸系统医学 呼吸系统医学
背景情况:
- 支气管热塑术 (BT) 是一种治疗严重喘的非药物治疗方法.
- 在患有严重,不可逆转的肺功能障碍的患者中,其安全性和有效性尚不清楚.
研究的目的:
- 评估BT在耐火性喘患者的疗效和安全性.
- 具体评估那些在1秒内严重受损的强迫呼气体积 (FEV1) 的人的结果.
主要方法:
- 15名耐火性喘患者的回顾性观察队列研究 (全球喘倡议第四或第五阶段).
- 严重受损空气流限制的患者 (FEV1 <60%) 与FEV1 ≥60%的患者进行了比较.
- 分析了BT前后的疗效和并发症.
主要成果:
- 在这两组中,BT显著改善了喘症状和生活质量.
- 强迫呼吸量在1秒内 (FEV1) 在严重损伤组 (G1) 显著改善,但在中度损伤组 (G2) 没有显著改善.
- 在G1的BT后没有出现恶化,而G2的4名患者需要全身皮质类固醇.
结论:
- 支气管热塑术对于耐火性喘患者,严重限制气流的患者来说是安全有效的.
- 结果与中度空气流量限制患者的结果相似,重症组的恶化较少.
相关概念视频
Chest Physiotherapy
441
Chest Physiotherapy (CPT) is a therapeutic technique used in respiratory care to improve ventilation, clear bronchial secretions, and enhance the efficiency of respiratory muscles. This therapy includes three primary procedures: postural drainage, percussion, and vibration. It can be performed on spontaneously breathing patients and those who are intubated and mechanically ventilated.
Purpose
CPT is primarily used for patients with excessive bronchial secretions who have difficulty clearing...
Purpose
CPT is primarily used for patients with excessive bronchial secretions who have difficulty clearing...
441
Antiasthma Drugs: β2-Adrenoceptor Agonists
250
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
250
COPD: Management Using Bronchodilators and Corticosteroids
195
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
195
Flail Chest-II
165
Managing flail chest, a condition characterized by a segment of the chest wall moving independently from the rest of the thoracic cage, requires a comprehensive approach. It includes a thorough assessment of the patient's condition, a diagnostic evaluation to determine the extent of the injury, and the implementation of appropriate medical interventions tailored to the individual's needs.
Assessment:
1. Clinical Evaluation:
History:
Assessment:
1. Clinical Evaluation:
History:
165
Drugs Used in Lower Respiratory Disorders: Overview
421
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
421
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
155
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
155


